COSM (Cosmos Health) NonCurrent Deferred Revenue: $0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

COSM Cosmos Health Inc COSM
24 GF Score
Price $0.22
GF Value $0.35
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Cosmos Health NonCurrent Deferred Revenue?

Cosmos Health COSM -4.68% 24 NonCurrent Deferred Revenue is $0.00 Mil as of Mar. 2026. GuruFocus rates COSM with a GF Score™ of 24/100 and a GF Value™ of $0.35 (Possible Value Trap). The stock has 6 warning signs investors should review.

Non-Current Deferred Revenue represents the non-current portion of deferred revenue amount as of the balance sheet date. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months.

Cosmos Health's non-current deferred revenue for the quarter that ended in Mar. 2026 was $0.00 Mil.

Cosmos Health NonCurrent Deferred Revenue Related Terms

Cosmos Health NonCurrent Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Cosmos Health's NonCurrent Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cosmos Health NonCurrent Deferred Revenue Chart

Cosmos Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
NonCurrent Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Cosmos Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
NonCurrent Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
COSM
24GF Score
Cosmos Health Inc COSM
NonCurrent Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Revenue of $0.00 Mil mean?
Cosmos Health (COSM) has a NonCurrent Deferred Revenue of $0.00 Mil as of Mar. 2026. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months. View historical data on Cosmos Health and its competitors.
Is Cosmos Health's NonCurrent Deferred Revenue too high?
Cosmos Health's current NonCurrent Deferred Revenue is $0.00 Mil. Overall, Cosmos Health has a GF Score™ of 24/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cosmos Health's NonCurrent Deferred Revenue compare to HKPD and MEDS?
Cosmos Health's NonCurrent Deferred Revenue of $0.00 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Revenue for a Medical Distribution company?
A good NonCurrent Deferred Revenue depends on the Medical Distribution industry context. However, NonCurrent Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Revenue mean?
A high NonCurrent Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months. View historical data on Cosmos Health and its competitors. Cosmos Health's current NonCurrent Deferred Revenue is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cosmos Health stock overvalued right now?
Based on GuruFocus' analysis, Cosmos Health (COSM) is currently considered Possible Value Trap. The stock's GF Value™ is $0.35, compared to a current price of $0.22 — trading 36% below its estimated fair value. The current NonCurrent Deferred Revenue is $0.00 Mil. Cosmos Health's overall GF Score™ is 24/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Revenue calculated?
NonCurrent Deferred Revenue is calculated from a company's financial statements. For Cosmos Health (COSM), the current NonCurrent Deferred Revenue is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cosmos Health (COSM) Overvalued in 2026?

Based on GuruFocus' analysis, Cosmos Health stock appears to be undervalued. The current stock price of $0.22 is trading 36% below its estimated GF Value™ of $0.35. GuruFocus considers Cosmos Health to be Possible Value Trap.

Key valuation signals for COSM:

  • NonCurrent Deferred Revenue: $0.00 Mil
  • GF Value™: $0.35 vs. price of $0.22 (36% below fair value)
  • GF Score™: 24/100 with 6 warning signs

No single metric tells the full story. See the COSM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cosmos Health Business Description

Other Exchanges V67A:Germany
Address 5 Agiou Georgiou Street, Pilea, Thessaloniki, GRC, 55438
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
24GF Score

Get the complete analysis for COSM

NonCurrent Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.22
Price
$0.35
GF Value